SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Biotech Showcase 2023
Event | 01. 10. 2023
Elizabeth Kelly will be participating on a panel titled "Finance Trends in Asia Pacific" on Tuesday, January 10th at the Biotech Showcase 2023 in San Francisco.
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.